Liver transplantation is the only curative alternative for selected patients with hepatocellular carcinoma (HCC) who are not eligible for resection and/or with decompensated cirrhosis. According to Milan criteria the 5-year survival rate is 70-85%, with a recurrence-free survival of 75%. However, HCC recurrence rate after liver transplantation remains a significant problem in the clinical practice. The prognosis in patients with HCC recurrence is poor. The treatment of choice for HCC recurrence is surgery, but it seems that a systemic treatment based on combination of an mTOR inhibitor with sorafenib can be used. Data on safety and efficacy are limited, clinical monitoring is necessary. The aim of this review is to underline the main concerns, pitfalls and warnings for these patients.

Mazzola A., Costantino A., Petta S., Bartolotta T.V., Raineri M., Sacco R., et al. (2015). Recurrence of hepatocellular carcinoma after liver transplantation: An update [10.2217/fon.15.239].

Recurrence of hepatocellular carcinoma after liver transplantation: An update

Bartolotta T. V.;Raineri M.;Brancatelli G.;Cabibbo G.
2015-01-01

Abstract

Liver transplantation is the only curative alternative for selected patients with hepatocellular carcinoma (HCC) who are not eligible for resection and/or with decompensated cirrhosis. According to Milan criteria the 5-year survival rate is 70-85%, with a recurrence-free survival of 75%. However, HCC recurrence rate after liver transplantation remains a significant problem in the clinical practice. The prognosis in patients with HCC recurrence is poor. The treatment of choice for HCC recurrence is surgery, but it seems that a systemic treatment based on combination of an mTOR inhibitor with sorafenib can be used. Data on safety and efficacy are limited, clinical monitoring is necessary. The aim of this review is to underline the main concerns, pitfalls and warnings for these patients.
Mazzola A., Costantino A., Petta S., Bartolotta T.V., Raineri M., Sacco R., et al. (2015). Recurrence of hepatocellular carcinoma after liver transplantation: An update [10.2217/fon.15.239].
File in questo prodotto:
File Dimensione Formato  
mazzola2015.pdf

Solo gestori archvio

Tipologia: Post-print
Dimensione 1.73 MB
Formato Adobe PDF
1.73 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/411913
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 37
social impact